Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Kurze Gold-Preis-Konsolidierung zum Einstieg in diese Aktie nutzen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
130 Leser
Artikel bewerten:
(0)

ProPhotonix Limited: ProPhotonix Offers New Higher Intensity UV Curing

New Compact UV LED Curing System from ProPhotonix Offering 20% Higher Intensity

COBRA Cure FX1 Max Delivers up to 6.4W/cm2 or 7.8J/cm2 From the Same FX1 Form Factor Maintaining Excellent Lifetime

SALEM, NH / ACCESSWIRE / April 3, 2019 / ProPhotonix Limited (OTC: STKR and London Stock Exchange - AIM: PPIX), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, is pleased to announce the release of COBRA Cure FX1 Max, a compact, fan-cooled UV LED curing system designed to deliver maximum power density and dose for applications where space is restricted.

In developing the COBRA Cure FX1 Max, ProPhotonix has utilized its expertise in optical, mechanical and electronic engineering to design a UV LED Curing system that offers 20% increased output (up to 6.4W/cm2 intensity and 7.8J/cm2 maximum dose at 2mm working distance) without compromising on LED lifetime and reliability. The new UV LED curing lamp has been independently tested to verify its lifetime.

COBRA Cure FX1 Max is built with Chip-on-Board LED technology for maximum intensity and uniformity. It delivers a consistent, stable and reliable cure from a compact, easy-to-install, UV lamp. COBRA Cure FX1 Max is ideal for UV curing in printing and 3D Printing applications as well as curing of coatings and adhesives.

Ken Reynolds, Business and Technology Manager, ProPhotonix said: "The COBRA Cure FX1 Max significantly improves the dose levels available to those requiring a compact, fan-cooled UV LED curing system. ProPhotonix COBRA Cure FX1 Max delivers a powerful solution allowing customers to optimize space requirements and meet their reliability needs. ProPhotonix recognizes the importance of innovation, quality and reliability to our customers and provides patented, UL and CE certified COBRA Cure FX1 products from our ISO- certified facility."

For more information on COBRA Cure FX1 Max, visit https://www.prophotonix.com/led-and-laser-products/uv-led-curing-systems/cobra-cure-fx1-max/ or contact ProPhotonix on sales@prophotonix.com

Contact:

ProPhotonix Limited

sales@prophotonix.com

Ken Reynolds, Business and Technology Manager

Tel: +353 (0)21 500 1313



About ProPhotonix

ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of LED illumination systems and laser diode modules for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Ushio, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's website at www.prophotonix.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: ProPhotonix Limited



View source version on accesswire.com:
https://www.accesswire.com/540922/ProPhotonix-Offers-New-Higher-Intensity-UV-Curing

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.